Table 2.

Patient characteristics

		Overall n = 252	ERAS Compliant (ERAS Pathways > = 10) n = 129	ERAS Non-compliant (ERAS Pathways < 10) n = 123	P Value
Age	Mean ± SD	60.07 ± 9.75	60.64 ± 9.14(n = 129)	59.46 ± 10.36(n = 123)	0.2345
Male	N(%)	209(82.94%)	106(82.17%)(n = 129)	103(83.74%)(n = 123)	0.7406
BMI	Mean ± SD	23.38 ± 3.34	23.39 ± 3.32(n = 123)	23.37 ± 3.39(n = 120)	0.9576
Anemia	N(%)	88(35.06%)	45(35.16%)(n = 128)	43(34.96%)(n = 123)	0.9739
Abnormal Creatinine	N(%)	22(8.80%)	11(8.59%)(n = 128)	11(9.02%)(n = 122)	0.9061
Comorbidity	N(%)	45(17.86%)	27(20.93%)(n = 129)	18(14.63%)(n = 123)	0.1921
ASA ≥ 3	N(%)	28(12.17%)	12(10.26%)(n = 117)	16(14.16%)(n = 112)	0.3655
Duration of surgery, min	Mean ± SD	272.70 ± 61.12	274.92 ± 59.51(n = 129)	270.37 ± 62.93(n = 123)	0.5559
Blood loss, mL	median (IQR)	100(50)	100(50)(n = 129)	100(100)(n = 123)	0.5135
Intraoperative transfusion (Yes)	N(%)	19(7.54%)	8(6.20%)(n = 129)	11(8.94%)(n = 123)	0.4100
Pathologic TNM stage					0.8760
I A	N(%)	31(12.30%)	18(13.95%)	13(10.57%)
I B	N(%)	24(9.52%)	12(9.30%)	12(9.76%)
II A	N(%)	41(16.27%)	23(17.83%)	18(14.63%)
II B	N(%)	36(14.29%)	15(11.63%)	21(17.07%)
III A	N(%)	53(21.03%)	27(20.93%)	26(21.14%)
III B	N(%)	50(19.84%)	26(20.16%)	24(19.51%)
III C	N(%)	17(6.75%)	8(6.20%)	9(7.32%)

ERAS enhanced recovery after surgery, BMI body mass index